Skip to content

A multicenter study on the significance of short-term preoperative calcium and Vitamin D3 supplementation in preventing hypocalcemia after total thyroidectomy

A multicenter study on the significance of short-term preoperative calcium and Vitamin D3 supplementation in preventing hypocalcemia after total thyroidectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107134
Enrollment
Unknown
Registered
2025-08-05
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Hypocalcemia after Thyroidectomy

Interventions

Control group:None
Calcium only group:Oral calcium (1800mg/d) was given for 1 days before surgery
Combined group:Oral calcium (1800mg/d) and vitamin D3 (alfacalcalcitol 1ug/d) were given for 1 days before surgery

Sponsors

RuiJin Hospital LuWan Branch, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-60 years; 2.Preoperative diagnosis or high suspicion of thyroid malignancy (TI-RADS =4a) confirmed by ultrasound or fine-needle aspiration; 3.Scheduled for total thyroidectomy with bilateral central lymph node dissection (with or without lateral neck dissection); 4.Willing to provide informed consent and comply with follow-up requirements.

Exclusion criteria

Exclusion criteria: 1.Previous neck surgery; 2.Benign thyroid tumors; 3.Parathyroid disorders; 4.Current use of calcium or vitamin D3 supplements for other medical conditions; 5.Long-term proton pump inhibitor use; 6.Long-term oral contraceptive or estrogen therapy; 7.Severe hepatic or renal insufficiency;

Design outcomes

Primary

MeasureTime frame
The serum calcium;The serum phosphorus;Serum albumin;Parathyroid hormone;Serum magnesium;Additional intravenous calcium supplementation after surgery;Postoperative hospital stay;

Secondary

MeasureTime frame
Number of tumors;Drainage;Number of lymph nodes;Number of positive lymph nodes;Parathyroid gland lose;Serum 25-hydroxyvitamin D;Maximum tumor diameter;

Countries

China

Contacts

Public ContactJin Xiaoli

RuiJin Hospital LuWan Branch, Shanghai Jiaotong University School of Medicine

susie.jin@hotmail.com+86 21 63864050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026